Glenmark Pharma earns FDA approval for potassium chloride tablets

The Food and Drug Administration approved Glenmark Pharamceuticals' potassium chloride tablets.

The tablets, used to treat a potassium deficiency, are a generic version of K Dur tablets produced by Merck Sharp & Dohm, a subsidiary of Kenilworth, N.J.-based Merck.

The K Dur tablets reported annual sales of $283 million for the 12-month period ending May 2016, according to IMS Health sales data.

India-based Glenmark Pharmaceuticals currently has 117 products authorized for distribution in the U.S. and 61 products pending approval from the FDA.

More articles on the drug market:

Patients in Texas and Florida gain easier access to opioid-overdose antidote naloxone
Eli Lily exceeds 2Q expectations thanks to new drug sales
Sen. Bernie Sanders' DNC speech tackles high prescription drug costs: 4 things to know

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Whitepapers

Featured Webinars